WTC Program Rejects Fatty Liver for 9/11 Heroes
Published Date: 4/7/2026
Notice
Summary
The World Trade Center Health Program reviewed requests to add fatty liver disease (hepatic steatosis) to its list of covered health conditions but found there isn’t enough proof to do so right now. This means no new benefits or treatments will be added for this condition at this time. The decision was made official on April 7, 2026, affecting 9/11 responders and survivors hoping for expanded coverage.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
No WTC Coverage for Fatty Liver
The WTC Health Program denied Petitions 029, 034, 035, and 062 and decided on April 7, 2026 that hepatic steatosis (fatty liver disease) will not be added to the List of WTC-Related Health Conditions. This means eligible 9/11 responders and survivors will not receive new WTC Health Program medical monitoring or treatment benefits for fatty liver disease at this time.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in